NGL Fine-Chem Limited (NGLFINE.BO)

INR 1116.95

(3.42%)

Total Assets Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual total assets in 2023 was 3.55 Billion INR , up 23.85% from previous year.
NGL Fine-Chem Limited's latest quarterly total assets in 2023 FY was 3.55 Billion INR , up 23.85% from previous quarter.
NGL Fine-Chem Limited reported annual total assets of 2.87 Billion INR in 2022, up 3.67% from previous year.
NGL Fine-Chem Limited reported annual total assets of 2.76 Billion INR in 2021, up 33.53% from previous year.
NGL Fine-Chem Limited reported quarterly total assets of 3.55 Billion INR for 2023 FY, up 23.85% from previous quarter.
NGL Fine-Chem Limited reported quarterly total assets of 3.22 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of NGL Fine-Chem Limited (2023 - 2008)

Historical Annual Total Assets of NGL Fine-Chem Limited (2023 - 2008)

Year	Total Assets	Total Assets Growth
2023	3.55 Billion INR	23.85%
2022	2.87 Billion INR	3.67%
2021	2.76 Billion INR	33.53%
2020	2.07 Billion INR	35.0%
2019	1.53 Billion INR	8.04%
2018	1.42 Billion INR	9.98%
2017	1.29 Billion INR	26.56%
2016	1.02 Billion INR	31.53%
2015	776.68 Million INR	16.76%
2014	665.17 Million INR	19.11%
2013	558.45 Million INR	17.83%
2012	473.96 Million INR	27.44%
2011	371.9 Million INR	17.26%
2010	317.15 Million INR	25.04%
2009	253.63 Million INR	24.59%
2008	203.57 Million INR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q3	- INR	-100.0%
2023 FY	3.55 Billion INR	23.85%
2023 Q2	3.22 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q4	3.55 Billion INR	0.0%
2022 FY	2.87 Billion INR	3.67%
2022 Q2	2.74 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q4	2.87 Billion INR	0.0%
2021 Q2	2.66 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q4	2.76 Billion INR	0.0%
2021 FY	2.76 Billion INR	33.53%
2021 Q1	- INR	-100.0%
2020 Q2	1.92 Billion INR	0.0%
2020 Q4	2.07 Billion INR	0.0%
2020 FY	2.07 Billion INR	35.0%
2019 Q4	1.53 Billion INR	0.0%
2019 FY	1.53 Billion INR	8.04%
2019 Q2	1.56 Billion INR	0.0%
2018 FY	1.42 Billion INR	9.98%
2018 Q4	1.42 Billion INR	0.0%
2018 Q2	1.38 Billion INR	0.0%
2017 Q2	1.07 Billion INR	0.0%
2017 Q4	1.29 Billion INR	0.0%
2017 FY	1.29 Billion INR	26.56%
2016 Q2	817.69 Million INR	0.0%
2016 FY	1.02 Billion INR	31.53%
2016 Q4	1.01 Billion INR	0.0%
2015 Q2	711.41 Million INR	0.0%
2015 Q4	775.06 Million INR	0.0%
2015 FY	776.68 Million INR	16.76%
2014 FY	665.17 Million INR	19.11%
2014 Q4	665.17 Million INR	0.0%
2014 Q2	640.95 Million INR	0.0%
2013 Q4	558.45 Million INR	0.0%
2013 FY	558.45 Million INR	17.83%
2013 Q2	539.34 Million INR	0.0%
2012 Q4	473.96 Million INR	0.0%
2012 FY	473.96 Million INR	27.44%
2011 Q4	371.9 Million INR	0.0%
2011 FY	371.9 Million INR	17.26%
2010 FY	317.15 Million INR	25.04%
2009 FY	253.63 Million INR	24.59%
2008 FY	203.57 Million INR	0.0%
2008 Q4	203.57 Million INR	0.0%

Peer Total Assets Comparison of NGL Fine-Chem Limited

Name	Total Assets	Total Assets Difference
Abbott India Limited	51.93 Billion INR	93.154%
Cipla Limited	327.17 Billion INR	98.913%
Gland Pharma Limited	106.61 Billion INR	96.665%
GlaxoSmithKline Pharmaceuticals Limited	35.73 Billion INR	90.051%
Kopran Limited	7.43 Billion INR	52.164%
Marksans Pharma Limited	26.8 Billion INR	86.738%
Pfizer Limited	42.28 Billion INR	91.592%
Sanofi India Limited	17.14 Billion INR	79.267%
SMS Pharmaceuticals Limited	10.34 Billion INR	65.619%